About Essentials T400
Further information to follow.
Medication Details
- Brand
Somaí- Designation
- Essentials T400
- Chemotype
- Type I: High THC
- Format
- Distillate with Cannabis Terpenes
- THC Potential Range (±10%)
- 360-440mg
- CBD Potential Range (±10%)
- <1mg
- Cultivated in
- Portugal
- Imported as
- Schedule II: Finished Product
- Formulated in
- Portugal
Stock Availability
We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.
Best-Known Status: Releaf
We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ. *Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed. Dispensing Patient Pharmacies
About Somai Pharmaceuticals Inc
Somaí Pharmaceuticals is a manufacturer of cannabinoid formulations for the European markets.
At Somaí, we are committed to delivering the full therapeutic value of medical cannabis to benefit patients across the world.
Our scientific expertise combined with an avant-garde approach creates novel treatments that truly engage the power of the plant to alleviate debilitating chronic conditions.
We demonstrate our clear vision in the way we conceptualise innovative pharmaceutical products derived from cannabis and make them a reality.
Our team of experts formulate the most effective active ingredients to maximise bioavailability and provide rapid, targeted relief for specific conditions. Furthermore, our innovative drug delivery approaches ensure wide accessibility to our range.
Through collaboration with leading clinical experts and researchers across a variety of therapy areas, we aim to produce tailored, effective products and address currently unmet clinical needs through our forward-thinking approach.
somaipharma.eu
Further National Health-Service Information on